Titre : Protéines de maintenance des minichromosomes

Protéines de maintenance des minichromosomes : Questions médicales fréquentes

Termes MeSH sélectionnés :

Plasma Exchange
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Protéines de maintenance des minichromosomes : Questions médicales les plus fréquentes", "headline": "Protéines de maintenance des minichromosomes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Protéines de maintenance des minichromosomes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-06", "dateModified": "2025-04-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Protéines de maintenance des minichromosomes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines chromosomiques nonhistones", "url": "https://questionsmedicales.fr/mesh/D002868", "about": { "@type": "MedicalCondition", "name": "Protéines chromosomiques nonhistones", "code": { "@type": "MedicalCode", "code": "D002868", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.664.235" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Composant-2 du complexe de maintenance des minichromosomes", "alternateName": "Minichromosome Maintenance Complex Component 2", "url": "https://questionsmedicales.fr/mesh/D064111", "about": { "@type": "MedicalCondition", "name": "Composant-2 du complexe de maintenance des minichromosomes", "code": { "@type": "MedicalCode", "code": "D064111", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.664.235.750.200" } } }, { "@type": "MedicalWebPage", "name": "Composant-3 du complexe de maintenance des minichromosomes", "alternateName": "Minichromosome Maintenance Complex Component 3", "url": "https://questionsmedicales.fr/mesh/D064126", "about": { "@type": "MedicalCondition", "name": "Composant-3 du complexe de maintenance des minichromosomes", "code": { "@type": "MedicalCode", "code": "D064126", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.664.235.750.300" } } }, { "@type": "MedicalWebPage", "name": "Composant-4 du complexe de maintenance des minichromosomes", "alternateName": "Minichromosome Maintenance Complex Component 4", "url": "https://questionsmedicales.fr/mesh/D064148", "about": { "@type": "MedicalCondition", "name": "Composant-4 du complexe de maintenance des minichromosomes", "code": { "@type": "MedicalCode", "code": "D064148", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.664.235.750.400" } } }, { "@type": "MedicalWebPage", "name": "Composant-5 du complexe de maintenance des minichromosomes", "alternateName": "Minichromosome Maintenance Complex Component 5", "url": "https://questionsmedicales.fr/mesh/D064150", "about": { "@type": "MedicalCondition", "name": "Composant-5 du complexe de maintenance des minichromosomes", "code": { "@type": "MedicalCode", "code": "D064150", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.664.235.750.500" } } }, { "@type": "MedicalWebPage", "name": "Composant-6 du complexe de maintenance des minichromosomes", "alternateName": "Minichromosome Maintenance Complex Component 6", "url": "https://questionsmedicales.fr/mesh/D064151", "about": { "@type": "MedicalCondition", "name": "Composant-6 du complexe de maintenance des minichromosomes", "code": { "@type": "MedicalCode", "code": "D064151", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.664.235.750.600" } } }, { "@type": "MedicalWebPage", "name": "Composant-7 du complexe de maintenance des minichromosomes", "alternateName": "Minichromosome Maintenance Complex Component 7", "url": "https://questionsmedicales.fr/mesh/D064168", "about": { "@type": "MedicalCondition", "name": "Composant-7 du complexe de maintenance des minichromosomes", "code": { "@type": "MedicalCode", "code": "D064168", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.664.235.750.700" } } }, { "@type": "MedicalWebPage", "name": "Composant-8 du complexe de maintenance des minichromosomes", "alternateName": "Minichromosome Maintenance Complex Component 8", "url": "https://questionsmedicales.fr/mesh/D064187", "about": { "@type": "MedicalCondition", "name": "Composant-8 du complexe de maintenance des minichromosomes", "code": { "@type": "MedicalCode", "code": "D064187", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.664.235.750.800" } } }, { "@type": "MedicalWebPage", "name": "Composant-9 du complexe de maintenance des minichromosomes", "alternateName": "Minichromosome Maintenance Complex Component 9", "url": "https://questionsmedicales.fr/mesh/D064188", "about": { "@type": "MedicalCondition", "name": "Composant-9 du complexe de maintenance des minichromosomes", "code": { "@type": "MedicalCode", "code": "D064188", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.664.235.750.900" } } } ], "about": { "@type": "MedicalCondition", "name": "Protéines de maintenance des minichromosomes", "alternateName": "Minichromosome Maintenance Proteins", "code": { "@type": "MedicalCode", "code": "D064110", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Qing Yang", "url": "https://questionsmedicales.fr/author/Qing%20Yang", "affiliation": { "@type": "Organization", "name": "Department of Hepatic Surgery and Liver transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, 600# Tianhe Road, Guangzhou, 510630, China." } }, { "@type": "Person", "name": "Binhui Xie", "url": "https://questionsmedicales.fr/author/Binhui%20Xie", "affiliation": { "@type": "Organization", "name": "Department of Hepatobiliary Surgery, The First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China." } }, { "@type": "Person", "name": "Hui Tang", "url": "https://questionsmedicales.fr/author/Hui%20Tang", "affiliation": { "@type": "Organization", "name": "Department of Hepatic Surgery and Liver transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, 600# Tianhe Road, Guangzhou, 510630, China." } }, { "@type": "Person", "name": "Wei Meng", "url": "https://questionsmedicales.fr/author/Wei%20Meng", "affiliation": { "@type": "Organization", "name": "Department of Hepatic Surgery and Liver transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, 600# Tianhe Road, Guangzhou, 510630, China." } }, { "@type": "Person", "name": "Changchang Jia", "url": "https://questionsmedicales.fr/author/Changchang%20Jia", "affiliation": { "@type": "Organization", "name": "Cell-gene Therapy Translational Medicine Research Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Efficacy of therapeutic plasma exchange in severe COVID-19 disease: A meta-analysis.", "datePublished": "2022-10-18", "url": "https://questionsmedicales.fr/article/36254849", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/vox.13367" } }, { "@type": "ScholarlyArticle", "name": "Therapeutic plasma exchange in patients with sepsis: Secondary analysis of a cluster-randomized controlled trial.", "datePublished": "2022-10-31", "url": "https://questionsmedicales.fr/article/36314372", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jca.22027" } }, { "@type": "ScholarlyArticle", "name": "Efficacy of plasma exchange in patients with anti-MDA5 rapidly progressive interstitial lung disease.", "datePublished": "2022-10-30", "url": "https://questionsmedicales.fr/article/36323067", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jaut.2022.102941" } }, { "@type": "ScholarlyArticle", "name": "Cost-minimisation analysis of plasma exchange versus IVIg in the treatment of autoimmune neurological conditions.", "datePublished": "2022-07-12", "url": "https://questionsmedicales.fr/article/35831856", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12913-022-08210-z" } }, { "@type": "ScholarlyArticle", "name": "Benefits of plasma exchange on mortality in patients with COVID-19: a systematic review and meta-analysis.", "datePublished": "2022-06-14", "url": "https://questionsmedicales.fr/article/35709964", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijid.2022.06.014" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Nucléoprotéines", "item": "https://questionsmedicales.fr/mesh/D009698" }, { "@type": "ListItem", "position": 5, "name": "Protéines chromosomiques nonhistones", "item": "https://questionsmedicales.fr/mesh/D002868" }, { "@type": "ListItem", "position": 6, "name": "Protéines de maintenance des minichromosomes", "item": "https://questionsmedicales.fr/mesh/D064110" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Protéines de maintenance des minichromosomes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Protéines de maintenance des minichromosomes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Protéines de maintenance des minichromosomes", "description": "Comment diagnostiquer une anomalie des protéines MCM ?\nQuels tests sont utilisés pour évaluer les MCM ?\nLes niveaux de MCM peuvent-ils être mesurés ?\nQuels marqueurs sont associés aux MCM ?\nLes MCM sont-elles liées à des cancers spécifiques ?", "url": "https://questionsmedicales.fr/mesh/D064110?mesh_terms=Plasma+Exchange&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Protéines de maintenance des minichromosomes", "description": "Quels symptômes indiquent une dysfonction des MCM ?\nLes symptômes sont-ils spécifiques aux MCM ?\nComment les MCM affectent-elles la santé cellulaire ?\nLes MCM sont-elles liées à des symptômes neurologiques ?\nPeut-on observer des symptômes précoces de dysfonction MCM ?", "url": "https://questionsmedicales.fr/mesh/D064110?mesh_terms=Plasma+Exchange&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Protéines de maintenance des minichromosomes", "description": "Peut-on prévenir les anomalies des MCM ?\nY a-t-il des tests de dépistage pour les MCM ?\nL'alimentation influence-t-elle les MCM ?\nLe stress affecte-t-il les MCM ?\nLes exercices physiques aident-ils les MCM ?", "url": "https://questionsmedicales.fr/mesh/D064110?mesh_terms=Plasma+Exchange&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Protéines de maintenance des minichromosomes", "description": "Quels traitements ciblent les MCM ?\nLes thérapies géniques peuvent-elles aider ?\nY a-t-il des médicaments pour les MCM ?\nComment la chimiothérapie affecte-t-elle les MCM ?\nLes traitements sont-ils personnalisés pour les MCM ?", "url": "https://questionsmedicales.fr/mesh/D064110?mesh_terms=Plasma+Exchange&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Protéines de maintenance des minichromosomes", "description": "Quelles complications peuvent survenir avec des anomalies MCM ?\nLes anomalies MCM sont-elles héréditaires ?\nComment les MCM affectent-elles le vieillissement ?\nLes MCM sont-elles liées à des maladies auto-immunes ?\nLes anomalies MCM peuvent-elles causer des troubles neurologiques ?", "url": "https://questionsmedicales.fr/mesh/D064110?mesh_terms=Plasma+Exchange&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Protéines de maintenance des minichromosomes", "description": "Quels facteurs augmentent le risque d'anomalies MCM ?\nL'exposition à des toxines influence-t-elle les MCM ?\nLe tabagisme affecte-t-il les MCM ?\nLe vieillissement est-il un facteur de risque pour les MCM ?\nLes antécédents familiaux influencent-ils les MCM ?", "url": "https://questionsmedicales.fr/mesh/D064110?mesh_terms=Plasma+Exchange&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anomalie des protéines MCM ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses de protéines peuvent identifier des anomalies." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les MCM ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'immunobuvardage et la PCR sont couramment utilisés pour évaluer les MCM." } }, { "@type": "Question", "name": "Les niveaux de MCM peuvent-ils être mesurés ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les niveaux de MCM peuvent être mesurés par des techniques de biologie moléculaire." } }, { "@type": "Question", "name": "Quels marqueurs sont associés aux MCM ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les marqueurs de prolifération cellulaire, comme Ki-67, sont souvent associés aux MCM." } }, { "@type": "Question", "name": "Les MCM sont-elles liées à des cancers spécifiques ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux élevés de MCM sont souvent associés à divers types de cancers." } }, { "@type": "Question", "name": "Quels symptômes indiquent une dysfonction des MCM ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies dans la réplication de l'ADN peuvent entraîner des symptômes variés." } }, { "@type": "Question", "name": "Les symptômes sont-ils spécifiques aux MCM ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, les symptômes peuvent varier selon le type de maladie associée aux MCM." } }, { "@type": "Question", "name": "Comment les MCM affectent-elles la santé cellulaire ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une mauvaise fonction des MCM peut entraîner des erreurs dans la réplication de l'ADN." } }, { "@type": "Question", "name": "Les MCM sont-elles liées à des symptômes neurologiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un lien entre les MCM et des troubles neurologiques." } }, { "@type": "Question", "name": "Peut-on observer des symptômes précoces de dysfonction MCM ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des signes précoces peuvent inclure des anomalies de croissance cellulaire." } }, { "@type": "Question", "name": "Peut-on prévenir les anomalies des MCM ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne hygiène de vie et un suivi médical régulier peuvent aider à prévenir." } }, { "@type": "Question", "name": "Y a-t-il des tests de dépistage pour les MCM ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques peuvent être proposés pour les personnes à risque élevé." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle les MCM ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut soutenir la santé cellulaire et la fonction des MCM." } }, { "@type": "Question", "name": "Le stress affecte-t-il les MCM ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Le stress chronique peut perturber la fonction cellulaire, y compris celle des MCM." } }, { "@type": "Question", "name": "Les exercices physiques aident-ils les MCM ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer la santé cellulaire et la fonction des MCM." } }, { "@type": "Question", "name": "Quels traitements ciblent les MCM ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des inhibiteurs spécifiques de MCM sont en cours de développement pour le cancer." } }, { "@type": "Question", "name": "Les thérapies géniques peuvent-elles aider ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie génique pourrait corriger les anomalies des MCM dans certains cas." } }, { "@type": "Question", "name": "Y a-t-il des médicaments pour les MCM ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments ciblant la voie de réplication de l'ADN sont en développement." } }, { "@type": "Question", "name": "Comment la chimiothérapie affecte-t-elle les MCM ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La chimiothérapie peut perturber la fonction des MCM, affectant la réplication cellulaire." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés pour les MCM ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être adaptés en fonction des profils de MCM des patients." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des anomalies MCM ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des cancers, des troubles de croissance et des maladies génétiques." } }, { "@type": "Question", "name": "Les anomalies MCM sont-elles héréditaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines anomalies peuvent être héréditaires, augmentant le risque de maladies." } }, { "@type": "Question", "name": "Comment les MCM affectent-elles le vieillissement ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des dysfonctionnements des MCM peuvent accélérer le vieillissement cellulaire et tissulaire." } }, { "@type": "Question", "name": "Les MCM sont-elles liées à des maladies auto-immunes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des recherches suggèrent un lien potentiel entre les MCM et certaines maladies auto-immunes." } }, { "@type": "Question", "name": "Les anomalies MCM peuvent-elles causer des troubles neurologiques ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans les MCM peuvent être associées à des troubles neurologiques." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'anomalies MCM ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs génétiques, environnementaux et liés au mode de vie peuvent augmenter le risque." } }, { "@type": "Question", "name": "L'exposition à des toxines influence-t-elle les MCM ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à certaines toxines peut perturber la fonction des MCM." } }, { "@type": "Question", "name": "Le tabagisme affecte-t-il les MCM ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme est un facteur de risque connu pour des anomalies dans la fonction des MCM." } }, { "@type": "Question", "name": "Le vieillissement est-il un facteur de risque pour les MCM ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut affecter la fonction des MCM et augmenter le risque de maladies." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils les MCM ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies liées aux MCM peuvent augmenter le risque." } } ] } ] }

Sources (10000 au total)

Efficacy of therapeutic plasma exchange in severe COVID-19 disease: A meta-analysis.

Therapeutic plasma exchange (TPE) has been used in severe COVID-19 disease to eliminate the cytokine storm. This meta-analysis aims to assess the effectiveness of TPE in reducing mortality in severe C... A comprehensive literature search was performed in PubMed, the Cochrane database and the International Clinical Trial Registry Platform (ICTRP). The random-effect model was used to calculate the risk ... The database identified 382 participants from six studies, including one randomized control trial. Egger's test did not detect any publication bias (p = 0.178). The random model analysis for mortality... The length of ICU stay in the TPE group was not different from standard care. However, this meta-analysis revealed a significant benefit of TPE in reducing mortality in severe COVID-19 disease compare...

Therapeutic plasma exchange in patients with sepsis: Secondary analysis of a cluster-randomized controlled trial.

Sepsis is life-threatening organ dysfunction caused by infection-related inflammatory response. Therapeutic plasma exchange (TPE) can remove inflammatory mediators and benefit patients in different di... This study was a secondary analysis of a randomized controlled trial. Critically ill patients with sepsis were divided into two groups according to whether treated with TPE. The primary outcome was th... Among the 2772 critically ill patients enrolled in the trial, 742 patients with sepsis were selected and 22 patients received TPE were matched with 22 control patients. No significant difference was f... TPE may be not associated with improvement of organ failure and mortality in critically ill patients with sepsis and may be associated with a prolonged ICU stay....

Efficacy of plasma exchange in patients with anti-MDA5 rapidly progressive interstitial lung disease.

Rapidly progressive interstitial lung disease (RP-ILD) is a frequent and severe manifestation of anti-MDA5 dermatomyositis (MDA5-DM) associated with poor outcome. The optimal treatment regimen for MDA... This French nationwide multicentre retrospective study included all MDA5-DM RP-ILD patients from 2012 to 2021 admitted to 18 centres. The primary endpoint was one-year transplant-free survival.... 51 patients with MDA5-DM RP-ILD (female 67%; mean age at disease onset: 51 ± 11.6 years) were included. Thirty-two (63%) patients required mechanical ventilation and twenty-five (49%) received PLEX. O... MDA5-DM RP-ILD is associated with poor rate of one-year transplant-free survival. The use of PLEX was not associated with a better outcome albeit they were mainly given to more severe patients. While ...

Cost-minimisation analysis of plasma exchange versus IVIg in the treatment of autoimmune neurological conditions.

Plasma exchange (PLEX) is an effective treatment for antibody-mediated neurological disorders and has been shown to be equally efficacious to intravenous immunoglobulin (IVIg) with comparable adverse ... We prospectively collected data from a cohort of patients who underwent PLEX at the Wessex Neurological Centre, UK, to perform a cost-minimisation analysis comparing PLEX to IVIg, the standard of care... The provision of PLEX was roughly half as costly when compared to what it would have been for IVIg (£886 per exchange vs £1778 per infusion or £4432 per cycle of 5 exchanges vs £8890 per cycle of 5 in... Our findings demonstrate that PLEX is more cost-effective than IVIg in this setting. Our study supports the economic case for development of plasma exchange centres in regional neurology units, a case...

Benefits of plasma exchange on mortality in patients with COVID-19: a systematic review and meta-analysis.

The COVID-19 pandemic continues, and the death toll continues to surge. This systematic review and meta-analysis aimed to determine the efficacy of therapeutic plasma exchange (TPE) on mortality in pa... A systematic search was made of PubMed, Embase, Cochrane Library, and clinicaltrials.gov, without language restrictions. Controlled clinical trials on treatment of COVID-19 with TPE, compared with sta... A total of six trials (enrolling 343 participants) met the inclusion criteria. Therapeutic plasma exchange showed significant effect on mortality (RR 0.41, 95% CI 0.24 to 0.69; P = 0.0008).... TPE significantly reduced mortality in hospitalized patients with moderate-to-critical COVID-19. Plasma exchange therapy should be considered for patients with COVID-19....

COVID-19-associated transverse myelitis treated by therapeutic plasma exchange: A case report.

Transverse myelitis (TM) is a very uncommon condition in children which can be associated with viral infections. Acute TM cases have been reported after Coronavirus disease 2019 (COVID-19) infection d... We report a child with TM related to severe acute respiratory syndrome coronavirus 2, who was successfully treated with therapeutic plasma exchange (TPE). Inability to walk and urinary retention were ... We demonstrated that a child diagnosed with acute TM related to COVID-19 infection, was successfully treated with TPE....

Efficacy and Safety of Plasma Exchange Combined with Hemoperfusion in the Treatment of Organophosphorus Poisoning: A Meta-Analysis.

The aim of the study was to systematically evaluate the efficacy and safety of plasma exchange combined with hemoperfusion in the treatment of organophosphorus poisoning.... PubMed, Embase, the Cochrane Library, China National Knowledge Internet, Wanfang database, and Weipu database were searched for articles about this subject. Literature screening and selection were con... 14 randomized controlled trials with 1,034 participants were included in this meta-analysis study, including 518 cases in plasma exchange combined with hemoperfusion group (the combination treatment g... The current evidence suggests that the combination of plasma exchange with hemoperfusion therapy can reduce the mortality of patients with organophosphorus poisoning, shorten the recovery time of chol...